O	0	9	Defective	Defective	JJ	B-NP
O	10	17	biliary	biliary	JJ	I-NP
O	18	24	copper	copper	NN	I-NP
O	25	34	excretion	excretion	NN	I-NP
O	35	37	in	in	IN	B-PP
O	38	44	Wilson	Wilson	NNP	B-NP
O	44	45	'	'	POS	B-NP
O	45	46	s	s	NNS	I-NP
O	47	54	disease	disease	NN	I-NP
O	54	55	:	:	:	O
O	56	59	the	the	DT	B-NP
O	60	64	role	role	NN	I-NP
O	65	67	of	of	IN	B-PP
O	68	82	caeruloplasmin	caeruloplasmin	NN	B-NP
O	82	83	.	.	.	O

O	84	92	Previous	Previous	JJ	B-NP
O	93	100	studies	study	NNS	I-NP
O	101	105	have	have	VBP	B-VP
O	106	112	failed	fail	VBN	I-VP
O	113	115	to	to	TO	I-VP
O	116	123	explain	explain	VB	I-VP
O	124	127	the	the	DT	B-NP
O	128	132	link	link	NN	I-NP
O	133	140	between	between	IN	B-PP
O	141	147	copper	copper	NN	B-NP
O	148	160	accumulation	accumulation	NN	I-NP
O	161	164	and	and	CC	O
O	165	173	abnormal	abnormal	JJ	B-NP
O	174	188	caeruloplasmin	caeruloplasmin	NN	I-NP
O	189	199	expression	expression	NN	I-NP
O	200	202	in	in	IN	B-PP
O	203	209	Wilson	Wilson	NNP	B-NP
O	209	210	'	'	POS	B-NP
O	210	211	s	s	JJ	I-NP
O	212	219	disease	disease	NN	I-NP
O	219	220	.	.	.	O

O	221	232	Furthermore	Furthermore	RB	B-ADVP
O	232	233	,	,	,	O
O	234	241	despite	despite	IN	B-PP
O	242	245	the	the	DT	B-NP
O	246	255	isolation	isolation	NN	I-NP
O	256	258	of	of	IN	B-PP
O	259	260	a	a	DT	B-NP
O	261	270	candidate	candidate	NN	I-NP
O	271	275	gene	gene	NN	I-NP
O	276	279	for	for	IN	B-PP
O	280	286	Wilson	Wilson	NNP	B-NP
O	286	287	'	'	POS	B-NP
O	287	288	s	s	NN	I-NP
O	289	296	disease	disease	NN	I-NP
O	296	297	,	,	,	O
O	298	303	which	which	WDT	B-NP
O	304	312	predicts	predict	VBZ	B-VP
O	313	314	a	a	DT	B-NP
O	315	324	defective	defective	JJ	I-NP
O	325	331	copper	copper	NN	I-NP
O	332	341	transport	transport	NN	I-NP
O	342	349	protein	protein	NN	I-NP
O	349	350	,	,	,	O
O	351	354	the	the	DT	B-NP
O	355	367	localization	localization	NN	I-NP
O	368	370	of	of	IN	B-PP
O	371	375	this	this	DT	B-NP
O	376	384	putative	putative	JJ	I-NP
O	385	392	protein	protein	NN	I-NP
O	393	396	and	and	CC	O
O	397	400	its	its	PRP$	B-NP
O	401	413	relationship	relationship	NN	I-NP
O	414	416	to	to	TO	B-PP
O	417	420	the	the	DT	B-NP
O	421	428	pathway	pathway	NN	I-NP
O	429	437	involved	involve	VBN	B-VP
O	438	440	in	in	IN	B-PP
O	441	447	copper	copper	NN	B-NP
O	448	457	excretion	excretion	NN	I-NP
O	458	461	and	and	CC	B-PP
O	462	464	to	to	TO	B-PP
O	465	479	caeruloplasmin	caeruloplasmin	NN	B-NP
O	480	486	remain	remain	VB	B-VP
O	487	494	unknown	unknown	JJ	B-ADJP
O	494	495	.	.	.	O

O	496	498	We	We	PRP	B-NP
O	499	502	now	now	RB	B-ADVP
O	503	510	present	present	VBP	B-VP
O	511	519	evidence	evidence	NN	B-NP
O	520	524	that	that	IN	B-SBAR
O	525	539	caeruloplasmin	caeruloplasmin	NN	B-NP
O	539	540	,	,	,	O
O	541	544	the	the	DT	B-NP
O	545	550	major	major	JJ	I-NP
B-Organism_substance	551	557	plasma	plasma	NN	I-NP
O	558	564	copper	copper	NN	I-NP
O	564	565	-	-	HYPH	O
O	565	573	carrying	carry	VBG	B-VP
O	574	581	protein	protein	NN	B-NP
O	581	582	,	,	,	O
O	583	585	is	be	VBZ	B-VP
O	586	593	present	present	JJ	B-ADJP
O	594	596	in	in	IN	B-PP
O	597	600	the	the	DT	B-NP
B-Organ	601	606	liver	liver	NN	I-NP
O	607	609	in	in	IN	B-PP
O	610	616	Wilson	Wilson	NNP	B-NP
O	616	617	'	'	POS	B-NP
O	617	618	s	s	NN	I-NP
O	619	626	disease	disease	NN	I-NP
O	626	627	,	,	,	O
O	628	631	and	and	CC	O
O	632	636	thus	thus	RB	B-ADVP
O	637	641	that	that	DT	B-NP
O	642	649	reduced	reduce	VBD	B-VP
O	650	661	circulating	circulate	VBG	B-NP
O	662	668	levels	level	NNS	I-NP
O	669	671	of	of	IN	B-PP
O	672	675	the	the	DT	B-NP
O	676	683	protein	protein	NN	I-NP
O	684	690	result	result	VBP	B-VP
O	691	695	from	from	IN	B-PP
O	696	697	a	a	DT	B-NP
O	698	702	post	post	AFX	I-NP
O	702	703	-	-	HYPH	I-NP
O	703	716	translational	translational	JJ	I-NP
O	717	723	defect	defect	NN	I-NP
O	724	726	in	in	IN	B-PP
O	727	730	the	the	DT	B-NP
O	731	740	secretory	secretory	JJ	I-NP
O	741	748	pathway	pathway	NN	I-NP
O	748	749	.	.	.	O

O	750	752	We	We	PRP	B-NP
O	753	757	have	have	VBP	B-VP
O	758	762	also	also	RB	I-VP
O	763	773	identified	identify	VBN	I-VP
O	774	775	a	a	DT	B-NP
O	776	781	novel	novel	JJ	I-NP
O	782	786	form	form	NN	I-NP
O	787	789	of	of	IN	B-PP
O	790	804	caeruloplasmin	caeruloplasmin	NN	B-NP
O	804	805	,	,	,	O
O	806	815	molecular	molecular	JJ	B-NP
O	816	822	weight	weight	NN	I-NP
O	823	826	125	125	CD	B-NP
O	827	829	kD	kD	NN	I-NP
O	829	830	,	,	,	O
O	831	836	which	which	WDT	B-NP
O	837	839	we	we	PRP	B-NP
O	840	847	propose	propose	VBP	B-VP
O	848	851	may	may	MD	B-VP
O	852	855	act	act	VB	I-VP
O	856	858	as	as	IN	B-PP
O	859	862	the	the	DT	B-NP
O	863	870	carrier	carrier	NN	I-NP
O	871	874	for	for	IN	B-PP
O	875	884	excretory	excretory	JJ	B-NP
O	885	891	copper	copper	NN	I-NP
O	892	896	into	into	IN	B-PP
B-Organism_substance	897	901	bile	bile	NN	B-NP
O	901	902	,	,	,	O
O	903	908	since	since	IN	B-SBAR
O	909	911	it	it	PRP	B-NP
O	912	914	is	be	VBZ	B-VP
O	915	923	normally	normally	RB	B-ADJP
O	924	931	present	present	JJ	I-ADJP
O	932	934	in	in	IN	B-PP
O	935	939	both	both	CC	O
B-Organ	940	945	liver	liver	NN	B-NP
O	946	949	and	and	CC	I-NP
B-Organism_substance	950	954	bile	bile	NN	I-NP
O	954	955	,	,	,	O
O	956	964	although	although	IN	B-SBAR
O	965	972	largely	largely	RB	B-ADJP
O	973	979	absent	absent	JJ	I-ADJP
O	980	984	from	from	IN	B-PP
B-Organism_substance	985	990	serum	serum	NN	B-NP
O	990	991	,	,	,	O
O	992	995	and	and	CC	O
O	996	1008	undetectable	undetectable	JJ	B-ADJP
O	1009	1011	in	in	IN	B-PP
B-Organism_substance	1012	1016	bile	bile	NN	B-NP
O	1017	1021	from	from	IN	B-PP
O	1022	1028	Wilson	Wilson	NNP	B-NP
O	1028	1029	'	'	POS	B-NP
O	1029	1030	s	s	NN	I-NP
O	1031	1038	disease	disease	NN	I-NP
O	1039	1047	patients	patient	NNS	I-NP
O	1047	1048	.	.	.	O

O	1049	1052	The	The	DT	B-NP
O	1053	1061	presence	presence	NN	I-NP
O	1062	1064	of	of	IN	B-PP
O	1065	1069	this	this	DT	B-NP
O	1070	1074	form	form	NN	I-NP
O	1075	1077	of	of	IN	B-PP
O	1078	1092	caeruloplasmin	caeruloplasmin	NN	B-NP
O	1093	1095	in	in	IN	B-PP
O	1096	1102	Wilson	Wilson	NNP	B-NP
O	1102	1103	'	'	POS	B-NP
O	1103	1104	s	s	NN	I-NP
O	1105	1112	disease	disease	NN	I-NP
B-Organ	1113	1118	liver	liver	NN	I-NP
O	1119	1127	suggests	suggest	VBZ	B-VP
O	1128	1132	that	that	IN	B-SBAR
O	1133	1134	a	a	DT	B-NP
O	1135	1142	related	related	JJ	I-NP
O	1143	1147	post	post	AFX	I-NP
O	1147	1148	-	-	HYPH	I-NP
O	1148	1161	translational	translational	JJ	I-NP
O	1162	1168	defect	defect	NN	I-NP
O	1169	1172	may	may	MD	B-VP
O	1173	1177	also	also	RB	I-VP
O	1178	1180	be	be	VB	I-VP
O	1181	1192	responsible	responsible	JJ	B-ADJP
O	1193	1196	for	for	IN	B-PP
O	1197	1200	its	its	PRP$	B-NP
O	1201	1208	absence	absence	NN	I-NP
O	1209	1213	from	from	IN	B-PP
B-Organism_substance	1214	1218	bile	bile	NN	B-NP
O	1219	1221	in	in	IN	B-PP
O	1222	1228	Wilson	Wilson	NNP	B-NP
O	1228	1229	'	'	POS	B-NP
O	1229	1230	s	s	JJ	I-NP
O	1231	1238	disease	disease	NN	I-NP
O	1238	1239	.	.	.	O

O	1240	1244	This	This	DT	B-NP
O	1245	1250	study	study	NN	I-NP
O	1251	1255	thus	thus	RB	B-ADVP
O	1256	1264	provides	provide	VBZ	B-VP
O	1265	1268	the	the	DT	B-NP
O	1269	1274	first	first	JJ	I-NP
O	1275	1284	plausible	plausible	JJ	I-NP
O	1285	1296	explanation	explanation	NN	I-NP
O	1297	1299	of	of	IN	B-PP
O	1300	1301	a	a	DT	B-NP
O	1302	1306	link	link	NN	I-NP
O	1307	1314	between	between	IN	B-PP
O	1315	1318	the	the	DT	B-NP
O	1319	1328	defective	defective	JJ	I-NP
O	1329	1335	copper	copper	NN	I-NP
O	1336	1345	excretion	excretion	NN	I-NP
O	1346	1349	and	and	CC	O
O	1350	1353	the	the	DT	B-NP
O	1354	1361	reduced	reduce	VBN	I-NP
B-Organism_substance	1362	1368	plasma	plasma	NN	I-NP
O	1369	1383	caeruloplasmin	caeruloplasmin	NN	I-NP
O	1383	1384	,	,	,	O
O	1385	1390	which	which	WDT	B-NP
O	1391	1403	characterize	characterize	VBP	B-VP
O	1404	1410	Wilson	Wilson	NNP	B-NP
O	1410	1411	'	'	POS	B-NP
O	1411	1412	s	s	JJ	I-NP
O	1413	1420	disease	disease	NN	I-NP
O	1420	1421	.	.	.	O

